← Leaderboards
Nancy A Rigotti
Massachusetts General Hospital
$18,154,837
Attributed
$28,132,698
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,132,698 · 11
By mechanism
R01$17,595,595 · 4
K12$4,172,655 · 1
R44$2,497,896 · 1
K24$1,453,755 · 1
RC1$996,284 · 1
M01$602,857 · 1
Top collaborators
- A Eden Evins8 shared
- Jennifer S Haas6 shared
- Elyse R Park6 shared
- Richard A Brown5 shared
- Hilary A. Tindle5 shared
- Cindy Jacobs3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Maurizio Fava$41,478,557
- C J Malanga$2,021,974
- Joanna Streck$1,406,806
- Nina Beth Gold$2,729,558
- Elyse R Park$12,238,672
Others in their field
Top investigators on “Smoking Cessation”
- Lloyd D Johnston · University Of Michigan At Ann Arbor$52,287,032
- Richard A Miech · Johns Hopkins University$46,640,555
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$38,193,270
- Ulrike Peters · Fred Hutchinson Cancer Research Center$35,830,035
- William J. Blot · Vanderbilt University$35,230,632
- Judith A James · Oklahoma Medical Research Foundation$34,326,590
Research focus
Smoking CessationCounselingProgramsClinical ResearchRandomizedBupropionSmokerSmokingHospitalsSmoking Cessation InterventionNicotine ReplacementDesignTelephoneTobaccoPrevalenceTobacco AbstinenceEvidence BasePharmacotherapyPharmaceutical PreparationsCostEnrollmentAdultSmoking InterventionSite
Grant awards (57)
Career Development Program in Substance Use and Addiction Medicine$533,472
K12 · FY2025 · DA
Career Development Program in Substance Use and Addiction Medicine$533,472
K12 · FY2024 · DA
Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use$584,690
R44 · FY2023 · DA
Career Development Program in Substance Use and Addiction Medicine$533,472
K12 · FY2023 · DA
Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use$1,913,206
R44 · FY2022 · DA
Assessing the integration of tobacco cessation treatment into lung cancer screening$1,109,934
R01 · FY2022 · CA
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$791,345
R01 · FY2021 · HL · contact PI
Assessing the integration of tobacco cessation treatment into lung cancer screening$744,556
R01 · FY2021 · CA
Career Development Program in Substance Use and Addiction Medicine$538,167
K12 · FY2021 · DA · contact PI
Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use$320,000
R42 · FY2021 · DA
Assessing the integration of tobacco cessation treatment into lung cancer screening$947,066
R01 · FY2020 · CA
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$805,232
R01 · FY2020 · HL · contact PI
Career Development Program in Substance Use and Addiction Medicine$508,113
K12 · FY2020 · DA · contact PI
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$810,130
R01 · FY2019 · HL · contact PI
Assessing the integration of tobacco cessation treatment into lung cancer screening$686,996
R01 · FY2019 · CA
Career Development Program in Substance Use and Addiction Medicine$508,653
K12 · FY2019 · DA · contact PI
Research Diversity Supplement Assessing the Integration of Tobacco Cessation Treatment into Lung Cancer Screening$205,793
R01 · FY2019 · CA
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$823,555
R01 · FY2018 · HL · contact PI
Assessing the integration of tobacco cessation treatment into lung cancer screening$723,961
R01 · FY2018 · CA
Career Development Program in Substance Use and Addiction Medicine$508,653
K12 · FY2018 · DA · contact PI
Extended Care for Smoking Cessation Following Psychiatric Hospitalization$500,312
R01 · FY2018 · MH
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$867,173
R01 · FY2017 · HL · contact PI
Extended Care for Smoking Cessation Following Psychiatric Hospitalization$586,270
R01 · FY2017 · MH
Career Development Program in Substance Use and Addiction Medicine$508,653
K12 · FY2017 · DA · contact PI
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$762,211
R01 · FY2016 · HL · contact PI
Extended Care for Smoking Cessation Following Psychiatric Hospitalization$599,003
R01 · FY2016 · MH
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$760,563
R01 · FY2015 · HL · contact PI
Extended Care for Smoking Cessation Following Psychiatric Hospitalization$610,305
R01 · FY2015 · MH
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$766,891
R01 · FY2014 · HL · contact PI
Extended Care for Smoking Cessation Following Psychiatric Hospitalization$680,772
R01 · FY2014 · MH
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$776,067
R01 · FY2013 · HL · contact PI
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$845,904
R01 · FY2012 · HL · contact PI
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers$432,823
R01 · FY2012 · HL · contact PI
Smoking Interventions for Hospital Patients:A Comparative Effectiveness Trial$496,689
RC1 · FY2010 · HL · contact PI
Smoking Interventions for Hospital Patients:A Comparative Effectiveness Trial$499,595
RC1 · FY2009 · HL · contact PI
Smoking Cessation Interventions for Health Care Settings$177,341
K24 · FY2009 · HL · contact PI
Smoking Cessation Interventions for Health Care Settings$177,341
K24 · FY2008 · HL · contact PI
Bupropion for Smoking Cessation in Postpartum Women$212,407
R21 · FY2007 · DA · contact PI
Smoking Cessation Interventions for Health Care Settings$177,341
K24 · FY2007 · HL · contact PI
Bupropion for Smoking Cessation in Postpartum Women$281,249
R21 · FY2006 · DA · contact PI
Smoking Cessation Interventions for Health Care Settings$177,341
K24 · FY2006 · HL · contact PI
Smoking Cessation Interventions for Health Care Settings$177,341
K24 · FY2005 · HL
SMOKING CESSATION IN INTERVENTIONS FOR HOSPITAL PATIENTS$113,410
K24 · FY2004 · HL
BUPROPION FOR EARLY INTERVENTION TO STOP TOBACCO USE IN HEART DISEASE$553
M01 · FY2004 · RR
SMOKING CESSATION IN INTERVENTIONS FOR HOSPITAL PATIENTS$113,410
K24 · FY2003 · HL
BUPROPION FOR HOSPITALIZED SMOKERS W CORONARY DISEASE$445,700
R01 · FY2002 · HL
Bupropion to Stop Tobacco Use in Heart Disease$200,768
M01 · FY2002 · RR
Bupropion to Stop Tobacco Use in Heart Disease$200,768
M01 · FY2002 · RR
SMOKING CESSATION IN INTERVENTIONS FOR HOSPITAL PATIENTS$113,410
K24 · FY2002 · HL
BUPROPION FOR HOSPITALIZED SMOKERS W CORONARY DISEASE$649,197
R01 · FY2001 · HL
Bupropion to Stop Tobacco Use in Heart Disease$200,768
M01 · FY2001 · RR
SMOKING CESSATION IN INTERVENTIONS FOR HOSPITAL PATIENTS$113,410
K24 · FY2001 · HL
Bupropion to Stop Tobacco Use in Heart Disease$0
M01 · FY2001 · RR
BUPROPION FOR HOSPITALIZED SMOKERS W CORONARY DISEASE$663,836
R01 · FY2000 · HL
SMOKING CESSATION IN INTERVENTIONS FOR HOSPITAL PATIENTS$113,410
K24 · FY2000 · HL
Bupropion to Stop Tobacco Use in Heart Disease$0
M01 · FY2000 · RR
Bupropion to Stop Tobacco Use in Heart Disease$0
M01 · FY2000 · RR